Abstract:Hepatocellular carcinoma (HCC) is a fatal digestive system cancer with unclear pathogenesis. M‐phase phosphoprotein 8 (MPP8) has been shown to play a vital role in several cancer types, such as non‐small cell lung cancer, gastric cancer and melanoma; however, there have been no studies into its role in HCC. The present study aimed to evaluate the role of MPP8 in regulating malignant phenotypes of liver cancer cells, and to further investigate the underlying mechanism. Bioinformatics analysis was performed to analyze related data from a public database, and to predict the potential microRNAs (miRNAs) that might target MPP8 mRNA; reverse transcription-quantitative PCR was used to measure the levels of mRNA and miRNA; western blotting was employed to detect protein levels; Cell Counting Kit‐8 (CCK‐8) and plate colony formation assays, wound healing assay and Transwell invasion assay were performed to evaluate the ability of cell proliferation, migration and invasion, respectively; dual‐luciferase reporter gene assay was performed to identify the target association. The results showed that MPP8 was a risk factor for the survival of patients with HCC, and was up‐regulated in HCC tissue samples and cell lines; MPP8 knockdown inhibited the proliferation, migration and invasion of liver cancer cells; MPP8 knockdown suppressed the PI3K/Akt pathway, and activation of this pathway reversed the inhibited liver cancer cell phenotypes by down‐regulating MPP8; miR‐576‐3p, which was low in liver cancer cells, negatively regulated MPP8 expression by directly targeting its mRNA; up‐regulating MPP8 expression reversed the inhibited signaling pathway and malignant phenotypes of liver cancer cells by miR‐576‐3p overexpression. In conclusion, the miR‐576‐3p/MPP8 axis regulates the proliferation, migration, and invasion of liver cancer cells through the PI3K/Akt signaling pathway. These findings lead novel insights into HCC progression, and propose MPP8 as a potential therapeutic target for HCC.

LncRNA RPPH1 Acts As a Molecular Sponge for Mir-122 to Regulate Wnt1/β-catenin Signaling in Hepatocellular Carcinoma

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

Hepatic Stellate Cells Promote the Progression of Hepatocellular Carcinoma Through Microrna-1246-rorα-wnt/β-catenin Axis

Mir-124 Inhibits Progression of Hepatocarcinoma by Targeting KLF4 and Promises a Novel Diagnostic Marker

Long Non-Coding RNA FEZF1-AS1 Promotes the Proliferation and Metastasis of Hepatocellular Carcinoma Via Targeting Mir-107/Wnt/β-catenin Axis

TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2–SAMD2–SMAD3 Axis

LncRNA RUSC1-AS1 Contributes to the Progression of Hepatocellular Carcinoma Cells by Modulating Mir-340-5p/creb1 Axis.

Mir-122 Enhances Sensitivity of Hepatocellular Carcinoma to Oxaliplatin Via Inhibiting MDR1 by Targeting Wnt/β-catenin Pathway.

Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression

LINC00205 promotes proliferation, migration and invasion of HCC cells by targeting miR-122-5p.

Hsa_circ_0101432 Promotes the Development of Hepatocellular Carcinoma (HCC) by Adsorbing Mir-1258 and Mir-622.

Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis

Mir-1204 Promotes Hepatocellular Carcinoma Progression Through Activating MAPK and C-Jun/ap1 Signaling by Targeting ZNF418

miR‐576‐3p/M‐phase phosphoprotein 8 axis regulates the malignant progression of hepatocellular carcinoma cells via the PI3K/Akt signaling pathway

MiR-126-3p Suppresses Tumor Metastasis and Angiogenesis of Hepatocellular Carcinoma by Targeting LRP6 and PIK3R2

Corrigendum to Hypoxia-Induced Lncrna EIF3J-AS1 Accelerates Hepatocellular Carcinoma Progression Via Targeting Mir-122-5p/ctnnd2 Axis.

MicroRNA Mir-124-3p Suppresses Proliferation and Epithelial–mesenchymal Transition of Hepatocellular Carcinoma Via ARRDC1 (arrestin Domain Containing 1)

LINC00152 Promotes Cell Cycle Progression in Hepatocellular Carcinoma Via Mir-193A/b-3p/ccnd1 Axis

RP11-81H3.2 Acts As an Oncogene Via Microrna-490-3p Inhibition and Consequential Tankyrase 2 Up-Regulation in Hepatocellular Carcinoma

Suppression of Hepatocellular Carcinoma Progression by Long Noncoding RNA Apolipoprotein C1 Pseudogene Via the Regulation of the Microrna-106B-pten Axis